Thiotepa

Product NDC: 71288-157
11-digit product format: 712880157
Labeler code: 71288
Product ID: 71288-157_d75a277e-a2ff-4409-8ef3-34b7fd2198f1
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Thiotepa
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRACAVITARY; INTRAVENOUS; INTRAVESICAL
Labeler: Meitheal Pharmaceuticals Inc
Application: ANDA216037
Marketing category: ANDA
Marketing start: 2023-12-26
Substance: THIOTEPA
Active strength: 100 mg/1
Pharmacologic classes: Alkylating Activity [MoA], Alkylating Drug [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A216037-001	THIOTEPA	THIOTEPA	15MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP		2023-12-26
A216037-002	THIOTEPA	THIOTEPA	100MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP		2023-12-26

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A216037-001	AP
A216037-002	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A216037-001	THIOTEPA	15MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A216037-002	THIOTEPA	100MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A216037-001	THIOTEPA	15MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A216037-002	THIOTEPA	100MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A216037-001	THIOTEPA	15MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A216037-002	THIOTEPA	100MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A216037-001	THIOTEPA	15MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A216037-002	THIOTEPA	100MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A216037-001	THIOTEPA	15MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A216037-002	THIOTEPA	100MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A216037-001	THIOTEPA	15MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A216037-002	THIOTEPA	100MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A216037-001	THIOTEPA	15MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A216037-002	THIOTEPA	100MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A216037-001	THIOTEPA	15MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A216037-002	THIOTEPA	100MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A216037-001	THIOTEPA	15MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A216037-002	THIOTEPA	100MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A216037-001	THIOTEPA	15MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A216037-002	THIOTEPA	100MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A216037-001	THIOTEPA	15MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A216037-002	THIOTEPA	100MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A216037-001	THIOTEPA	15MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A216037-002	THIOTEPA	100MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A216037-001	THIOTEPA	15MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A216037-002	THIOTEPA	100MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A216037-001	THIOTEPA	15MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A216037-002	THIOTEPA	100MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A216037-001	THIOTEPA	15MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A216037-002	THIOTEPA	100MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`8072bd15b7f6…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A216037-001	THIOTEPA	15MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A216037-002	THIOTEPA	100MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A216037-001	THIOTEPA	15MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	A216037-002	THIOTEPA	100MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`1c564ffb4f44…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A216037-001	THIOTEPA	15MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A216037-002	THIOTEPA	100MG/VIAL	POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL	AP	2023-12-26	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A216037-001	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A216037-002	AP	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A216037-001	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A216037-002	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A216037-001	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A216037-002	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A216037-001	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A216037-002	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A216037-001	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A216037-002	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A216037-001	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A216037-002	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A216037-001	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A216037-002	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A216037-001	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A216037-002	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A216037-001	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A216037-002	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A216037-001	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A216037-002	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A216037-001	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A216037-002	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A216037-001	AP	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A216037-002	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A216037-001	AP	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A216037-002	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A216037-001	AP	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A216037-002	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A216037-001	AP	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A216037-002	AP	1	`8072bd15b7f6…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A216037-001	AP	1	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A216037-002	AP	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A216037-001	AP	1	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	A216037-002	AP	1	`1c564ffb4f44…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A216037-001	AP	1	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A216037-002	AP	1	`a50c72e98297…`

Additional Listing Data#

Finished product: Yes
Brand name base: Thiotepa
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
THIOTEPA	100 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
905Z5W3GKH	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1660004	Internal RxNorm lookup
1660009	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
4b4725eb-95f1-45cc-852f-152beb5f1e2c	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
b9d03845-c04b-46cb-bb7e-9c6cffe3c163	Product name	4	20250618
d48e4a3f-d6a3-47a1-9357-dd5939f6049d	Product name	1	20250227
d4b5276b-261e-446e-ba03-7cf7bbc1d8af	Product name	3	20220718

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
71288-157-10	Thiotepa	1 in 1 VIAL, SINGLE-DOSE	INJECTION, POWDER, FOR SOLUTION	1		4
71288-157-10	Thiotepa	1 in 1 CARTON	INJECTION, POWDER, FOR SOLUTION	1		4

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
71288-157-10	EA - Each	71288-157	2354480f-9dd6-4123-977c-13b0f33b8e19	1	2024-01-04

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
71288-157	THIOTEPA INJECTION, POWDER, FOR SOLUTION [MEITHEAL PHARMACEUTICALS INC]	4	Current NDC, 2 package rows	20231229_4b4725eb-95f1-45cc-852f-152beb5f1e2c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Thiotepa	THIOTEPA	Meitheal Pharmaceuticals Inc	4b4725eb-95f1-45cc-852f-152beb5f1e2c	2023-12-27	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 216037 application number: ANDA216037 ndc (product): 71288-157

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
905Z5W3GKH	THIOTEPA	52-24-4	THIOTEPA

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1660004	thiotepa 100 MG Injection	PSN	4b4725eb-95f1-45cc-852f-152beb5f1e2c	4
1660009	thiotepa 15 MG Injection	PSN	4b4725eb-95f1-45cc-852f-152beb5f1e2c	4
1660004	thiotepa 100 MG Injection	SCD	4b4725eb-95f1-45cc-852f-152beb5f1e2c	4
1660009	thiotepa 15 MG Injection	SCD	4b4725eb-95f1-45cc-852f-152beb5f1e2c	4
1660004	TSPA 100 MG Injection	SY	4b4725eb-95f1-45cc-852f-152beb5f1e2c	4
1660009	TSPA 15 MG Injection	SY	4b4725eb-95f1-45cc-852f-152beb5f1e2c	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Sample	Exclude flag	Status
71288-157-10	71288015710	1 VIAL, SINGLE-DOSE in 1 CARTON (71288-157-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE	2023-12-26	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Thiotepa	Meitheal Pharmaceuticals Inc \| Kindos Pharmaceuticals Co., Ltd.	2023-12-27	HUMAN PRESCRIPTION DRUG LABEL	4